Abstract Details
Activity Number:
|
421
|
Type:
|
Topic Contributed
|
Date/Time:
|
Tuesday, August 6, 2013 : 2:00 PM to 3:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #310100 |
Title:
|
Quality-Adjusted Survival Analysis Under Therapeutic Setting
|
Author(s):
|
Suddhasatta Acharyya*+ and Ren He
|
Companies:
|
Novartis Pharmaceuticals Corporation and UCLA
|
Keywords:
|
survival ;
quality-of-life ;
oncology
|
Abstract:
|
A critical question, especially, in the context of oncology trials is whether and how to incorporate efficacy endpoints such as death or disease progression into the mix containing one or more instrument-based metrics. Commonly, a composite endpoint that incorporates both patient-reported subjective outcomes and objectively measured efficacy endpoints (such as disease progression or death) is used. Such an approach could be problematic, especially, when working with a time-to-event composite end-point (such as 'time to deterioration' or TTD), as it often requires specifying ad-hoc rules for defining events and censorings. An alternative approach is to use a modified overall survival type analysis, where instead of the usual survival-time, a 'quality-adjusted' version of it is analyzed. One popular such measure is the Q-TWiST, which is described as the 'time without symptoms and toxicity'. Originally, QTWiST was developed for the adjuvant setting but has since been extended in several directions. In this project, we adapt the QTWiST methodology to our specific situation, which is a two-arm randomized phase III oncology study, in a therapeutic setting.
|
Authors who are presenting talks have a * after their name.
Back to the full JSM 2013 program
|
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.